ACE2 and COVID-19: An age-related increase in pulmonary expression of ACE2 in the pneumocytes of the lungs, as well as increased ACE2 expression in older patients who require ventilation in comparison to older non-ventilated patients, was associated with greater severity and mortality in COVID-19.